Cargando…

A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma

ABSTRACT: BACKGROUND: The role of chemotherapy in high-risk soft tissue sarcoma is controversial. Though many patients undergo initial curative resection, distant metastasis is a frequent event, resulting in 5-year overall survival rates of only 50-60%. Neo-adjuvant and adjuvant chemotherapy (CTX) h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitt, Thomas, Lehner, Burkhard, Kasper, Bernd, Bischof, Marc, Roeder, Falk, Dietrich, Sascha, Dimitrakopoulou-Strauss, Antonia, Strauss, Ludwig G, Mechtersheimer, Gunhild, Wuchter, Patrick, Ho, Anthony D, Egerer, Gerlinde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248452/ https://www.ncbi.nlm.nih.gov/pubmed/22152120 http://dx.doi.org/10.1186/1471-2407-11-510

Ejemplares similares

Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial
por: Roeder, Falk, et al.
Publicado: (2014)

The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin
por: Kasper, Bernd, et al.
Publicado: (2009)

Trabectedin for Metastatic Soft Tissue Sarcoma: A Retrospective Single Center Analysis
por: Schmitt, Thomas, et al.
Publicado: (2010)

TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities
por: Koelsche, Christian, et al.
Publicado: (2014)

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2016)

The Therapeutic Role of Plastic and Reconstructive Surgery in the Interdisciplinary Treatment of Soft-Tissue Sarcomas in Germany—Cross-Sectional Results of a Prospective Nationwide Observational Study (PROSa)
por: Thomas, Benjamin, et al.
Publicado: (2022)

Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas
por: Renner, Marcus, et al.
Publicado: (2013)

Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor
por: Dietrich, Sascha, et al.
Publicado: (2009)

Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2012)

Positron Emission Tomography as a Surrogate Marker for Evaluation of Treatment Response in Patients with Desmoid Tumors under Therapy with Imatinib
por: Kasper, Bernd, et al.
Publicado: (2013)

A Systematic Review and Illustrative Case Presentation of Low-Grade Myofibroblastic Sarcoma (LGMS) of the Extremities
por: Schenker, Astrid, et al.
Publicado: (2023)

Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis
por: Roeder, Falk, et al.
Publicado: (2014)

Correlation of Dynamic PET and Gene Array Data in Patients with Gastrointestinal Stromal Tumors
por: Strauss, Ludwig G., et al.
Publicado: (2012)

Environmental impact assessment (EIA) : cutting edge for the twenty-first century
por: Gilpin, Alan
Publicado: (1995)

EIA effectiveness in Vietnam: key stakeholder perceptions
por: Clarke, B.D., et al.
Publicado: (2021)

609. Development of an Aspergillus Antigen Detection EIA
por: Bridges, Nicole, et al.
Publicado: (2023)

Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence
por: Omlor, Georg W., et al.
Publicado: (2019)

Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic (18)F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Immuno-Imaging (PET/SPECT)–Quo Vadis?
por: Kramer, Carsten S., et al.
Publicado: (2022)

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers
por: Celik, Betül, et al.
Publicado: (2013)

Toxin Detection by Cell Culture Neutralization Assay [CYT] and Toxin based EIA [Tox EIA] among Recurrent Episodes of CDI Diagnosed by PCR
por: Kamboj, Mini, et al.
Publicado: (2017)

Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
por: Frezza, Anna Maria, et al.
Publicado: (2014)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Application of F-18-Sodium Fluoride (NaF) Dynamic PET-CT (dPET-CT) for Defect Healing: A Comparison of Biomaterials in an Experimental Osteoporotic Rat Model
por: Cheng, Caixia, et al.
Publicado: (2014)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Quantitative, Dynamic (18)F-FDG PET/CT in Monitoring of Smoldering Myeloma: A Case Report
por: Sachpekidis, Christos, et al.
Publicado: (2021)

Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2020)

Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2023)

Expression of ORF2 protein of TTV for development of EIA system
por: Singh, Shiwani, et al.
Publicado: (2012)

Comparison between (68)Ga-bombesin ((68)Ga-BZH3) and the cRGD tetramer (68)Ga-RGD(4 )studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line
por: Cheng, Caixia, et al.
Publicado: (2011)

Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patients
por: Omlor, Georg W., et al.
Publicado: (2019)

Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial
por: Askoxylakis, Vasileios, et al.
Publicado: (2012)

Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database
por: Kantidakis, Georgios, et al.
Publicado: (2022)

Anti-HBc IgM and anti-delta screening by EIA method.
por: Kim, J. S., et al.
Publicado: (1986)

2366. PCR Followed by Toxin EIA for the Diagnosis of C. difficile Infection
por: Zhang, Yu, et al.
Publicado: (2019)

RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site?
por: Mechtersheimer, Gunhild, et al.
Publicado: (2021)

Deep Learning for the Classification of Non-Hodgkin Lymphoma on Histopathological Images
por: Steinbuss, Georg, et al.
Publicado: (2021)

Intraoperative radiation therapy (IORT) in soft-tissue sarcoma
por: Roeder, Falk, et al.
Publicado: (2017)

Functional Imaging with (18)F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient
por: Sachpekidis, Christos, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_80cf40c456ib3u04spr2584cia